secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001906324-26-000013
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho prelim Q1 rev $615-620M; weaker respiratory season, China headwinds
-------------------------------------------------------------------------------

- Prelim Q1 2026 revenue of $615-$620M; U.S. flu-like illness visits down ~30% YoY.
- China distributor sales slow on proposed NHSA reimbursement cuts; EMEA orders delayed by Middle East conflict.
- Q1 2026 free cash flow guided to negative $(65)-$(70)M; positive full-year still expected.
- Low end of FY 2026 guidance remains achievable; full discussion on May 5 earnings call.
- Core business (>70% of total rev) remains strong; cost actions underway to drive 2026 performance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632426000013/0001906324-26-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632426000013/qdel-20260415.htm
  HTML page:      https://secwatch.observer/filing/0001906324-26-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer